Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation study
about
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsCeftobiprole medocaril in the treatment of hospital-acquired pneumoniaIndividualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumoniaCeftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.Exposure to ceftobiprole is associated with microbiological eradication and clinical cure in patients with nosocomial pneumonia.Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach.Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
P2860
Q28066877-A0482DD4-A9BE-4AD5-8352-48533FD50A16Q28085517-BF08044E-D8C5-44EA-B8EE-C35CDC4AAE07Q34274190-24277EA6-8FD2-4024-B81C-0CE2A5E6F3E6Q34414748-88B1B109-4085-4868-86AB-6CAEDC306DEFQ34433342-68D7D964-C3AD-4E1A-9B80-743488EE399FQ37308807-758C821C-FB8B-4CA0-AC7A-D688F297B993Q37713040-A1AC02F3-1852-4335-AA90-FF3D4BADB112Q39164183-4B9EF709-4FD5-46DD-8792-41076EC23F74Q39983037-57CA67B1-1575-43EC-B747-784E17BD4E31Q44566052-64FBC3A2-E598-48E2-90AC-8C73BC555669Q46255695-C8B9629F-BFDD-4100-A3BD-ECA20AE7EC09
P2860
Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation study
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Monte Carlo simulations based ...... a patients: a validation study
@en
type
label
Monte Carlo simulations based ...... a patients: a validation study
@en
prefLabel
Monte Carlo simulations based ...... a patients: a validation study
@en
P2093
P2860
P356
P1476
Monte Carlo simulations based ...... a patients: a validation study
@en
P2093
Anne H Schmitt-Hoffmann
Anouk E Muller
Johan W Mouton
Nieko Punt
P2860
P304
P356
10.1128/AAC.02292-12
P407
P577
2013-02-12T00:00:00Z